D-Propargylglycine is a non-proteinogenic amino acid derivative featuring a glycine backbone bearing a propargyl side chain (-CH2-C≡CH) and existing as a free amino acid with both amino and carboxyl functional groups. The molecule is specified as the D stereoisomer at the α-carbon and contains a terminal alkyne that provides a defined chemical handle for bioorthogonal conjugation chemistry while remaining compatible with amino-acid-based coupling strategies. D-Propargylglycine is commonly used in peptide and small-molecule synthesis to introduce an alkyne functionality for subsequent labeling, crosslinking, or detection workflows in chemical biology and analytical method development.
D-Propargylglycine is a D-configured amino acid bearing a propargyl side chain, providing a stereochemically defined chiral center alongside a primary amino functionality and a carboxylic acid group. The terminal alkyne is a chemically distinctive handle for selective derivatization through copper-catalyzed azide-alkyne cycloaddition, thiol-yne chemistry, and oxidative or hydrogenation transformations. As an amino acid scaffold, D-Propargylglycine can be incorporated into peptide-like sequences via standard amide bond formation, while its D-configuration supports stereocontrolled synthesis of chiral amino acid derivatives and peptidomimetic motifs. The combination of an amino acid backbone and a reactive propargyl group makes it a practical intermediate for constructing functionalized biomolecules, enzyme probes, and downstream synthetic building blocks.
1. Peptide Synthesis
D-Propargylglycine is applied in peptide synthesis and peptide-coupling chemistry as a D-configured amino acid building block for assembling amide-linked sequences. The amino acid backbone supports N- and C-terminal functionalization strategies, while the propargyl side chain can remain protected or be introduced as a reactive handle depending on the coupling and deprotection schedule. Alkyne compatibility with common peptide coupling conditions enables incorporation into peptide analogs that later undergo click conjugation or orthogonal functional group transformations. D-Propargylglycine-derived peptides can serve as substrates for mechanistic studies, as scaffolds for generating libraries of alkyne-functionalized analogs, and as intermediates for further side-chain modification in synthetic peptide workflows.
2. Bioconjugation Chemistry
D-Propargylglycine functions in bioconjugation and chemical biology as an alkyne-bearing amino acid suitable for post-synthetic labeling. The terminal propargyl group participates in azide-alkyne cycloaddition to install fluorescent tags, affinity handles, or solubilizing groups onto peptides, proteins, and polymeric conjugates. The D-stereochemistry can be leveraged to tune stability against proteolysis when incorporated into peptide segments or biomolecule linkers, supporting the preparation of stereochemically defined conjugation reagents. Downstream derivatization can generate click-ready biomolecule conjugates and analytical standards for monitoring labeling efficiency and conjugate identity in applied biochemical research.
3. Enzyme Studies
D-Propargylglycine is used in enzyme studies and biochemical probe design where amino acid recognition elements can be paired with a reactive propargyl side chain. The amino acid framework can be incorporated into substrate-mimicking sequences or inhibitor-like analogs, and the alkyne can enable covalent or proximity-assisted labeling reactions under conditions chosen for the target enzyme class. The D-configuration provides a stereochemical dimension that may alter binding orientation and metabolic stability relative to L analogs, supporting mechanistic interpretation in structure-function investigations. Probe derivatives prepared from D-Propargylglycine can be used to map active-site accessibility, track enzymatic processing, or generate labeled intermediates for downstream analytical characterization.
4. Chiral Building Blocks
D-Propargylglycine is applied as a chiral amino acid intermediate for stereoselective synthesis of functionalized derivatives and peptidomimetic fragments. The D-configured stereocenter allows controlled generation of chiral propargyl-containing building blocks, including N-protected amino acids, ester derivatives, and side-chain-modified analogs for subsequent coupling chemistry. The propargyl moiety can be transformed into diverse functional groups, such as azide, triazole-linked motifs, or cyclized products, enabling iterative construction of complex chiral scaffolds. Synthetic routes that begin with D-Propargylglycine can feed into fine chemical synthesis and process development for laboratories preparing stereodefined intermediates used in peptide analog libraries and specialty molecular construction.
5. Pharmaceutical Manufacturing
D-Propargylglycine is relevant to pharmaceutical manufacturing and process chemistry as an amino acid starting material for producing alkyne-functional intermediates used in medicinal chemistry workflows. The carboxylic acid and amino functionality support protection-group strategies that are compatible with scalable peptide coupling operations and controlled deprotection steps during intermediate preparation. The terminal alkyne can serve as a manufacturing-stage handle for downstream conjugation to heterocycles, linkers, or scaffold fragments, including click-reactive intermediates that simplify late-stage functionalization. D-Propargylglycine-derived intermediates can therefore support industrial synthesis of chiral building blocks and functionalized molecular entities used in applied small-molecule and peptide-analog development programs.
2. Myotropic activity of allatostatins in tenebrionid beetles
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More